Last reviewed · How we verify
NCT05294016: CBRA
Smart Bra for Diagnosing Breast Cancer
NA trial testing BRA CONNECT device in Breast Cancer in 70 participants. Participants enrolled and being followed up; not accepting new ones.
10 July 2025
Quick facts
| Lead sponsor | Hopital Nord Franche-Comte |
|---|---|
| Phase | NA |
| Status | Active, enrolled |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | screening |
| Enrollment | 70 |
| Start date | 13 April 2022 |
| Primary completion | 10 July 2025 |
| Estimated completion | 28 August 2026 |
| Sites | 2 locations across France |
Drugs / interventions tested
- BRA CONNECT device
Conditions studied
- Breast Cancer — all drugs for Breast Cancer →
- Medical Device — all drugs for Medical Device →
Sponsor
Hopital Nord Franche-Comte
Who can join
18 and older, female only, with Breast Cancer or Medical Device. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This project aims to assess the ability of a portable and connected medical device to detect breast abnormalities, for breast cancer screening. It will accelerate technological progress in the face of breast cancer.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05294016
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Breast Cancer
Currently open trials in the same condition.
- NCT06148038 — CBD for Breast Cancer Primary Tumors · Phase 1 · recruiting
- NCT07405801 — A Phase II Study Evaluating the Efficacy and Safety of Inavolisib Plus Ribociclib Plus Fulvestrant Versus Placebo Plus R · Phase 2 · recruiting
- NCT07285993 — Detection and Outcomes in Metastatic Invasive Lobular Breast Cancer Through Novel F-18 FAP PET · Phase 2 · recruiting
- NCT07510698 — Same-Day Awake Mastectomy With Immediate Breast Reconstruction for Patients With Breast Cancer · NA · recruiting
- NCT06768931 — Biolosion Combined Standard Neoadjuvant Therapy to Treat Triple-negative Breast Cancer · Phase 2 · recruiting
Other Hopital Nord Franche-Comte trials
Trials by the same sponsor.
- NCT06884735 — Virtual Reality Exposure Therapy (VRET) in Psychomotor Disadaptation Syndrome · NA · not yet recruiting
- NCT07108920 — Analysis of Balance Disorders After Botulinum Toxin Treatment in the Rectus Femoris in Patients With a Stiff Knee Gait · recruiting
- NCT06856889 — Systematic Ultrasound in the Initial Assessment of Ankle Sprain · completed
- NCT06872450 — Informational Tool for Smoking Cessation in COPD Patients · completed
- NCT06484023 — Posterior Tibial Transcutaneous Neurostimulation in Idiopathic Overactive Bladder · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05294016 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hopital Nord Franche-Comte
- Last refreshed: 27 February 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05294016.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing